- Sports News : New Tongan administrators apply for rugby league membership [03/07/2020 - Tonga]
- Sports News : England coach Eddie Jones plans stunning raid for 'next All Blacks sensation' Hoskins Sotutu [03/07/2020 - United Kingdom]
- Business News : Niue completes ratification of PACER Plus agreement [03/07/2020 - Niue]
- Business News : Travel Bubble trouble – the options for Palau [03/07/2020 - Palau]
- Business News : World Bank strengthens partnership with the Federated States of Micronesia [03/07/2020 - Micronesia, Federated States of]
- Business News : Niue national budget address will be announced on Wednesday 08 July [03/07/2020 - Niue]
- Business News : Vanuatu exports - COVID-19 and extreme weather worry experts [03/07/2020 - Vanuatu]
- Business News : COVID-19 creates tough times for Kiribati’s world class tuna industry [03/07/2020 - Kiribati]
- News : Tonga opens border starting next week to repatriate stranded nationals in Fiji [03/07/2020 - Tonga]
- News : Palau’s envoy, Ngedikes Olai Uludong elected VP of UNGA [03/07/2020 - United States]
- News : Pacific Humanitarian Pathway unlocking borders to save lives during COVID-19 [03/07/2020 - Fiji]
- News : An estimate of USD$22 million for Pacific Humanitarian Pathway-COVID-19 [03/07/2020 - Fiji]
- Sponsored : Oceania National Olympic Committees (ONOC)
The World Health Organisation has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was taking the drug to help prevent infection.
“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,” Tedros told an online briefing.
He said the other arms of the trial - a major international initiative to hold clinical tests of potential treatments for the virus - were continuing.
The WHO has previously recommended against using hydroxychloroquine to treat or prevent coronavirus infections, except as part of clinical trials.
Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution.
Pacific Islands News Association
Who & What is PINA?
International News Safety Institute (INSI)
Media Helping Media